The seemingly increasing number of “adverse event reports” sent to the FDA has caused the number of hip replacement lawsuits to be filed against DePuy Othropaedics, manufacturers of the faulty ASL XL Acetabular System and AS Hip Resurfacing system Fast action by the company has resulted from this increased number of reports On the new site of the FDA states, “FDA is actively working in several areas to further assess the safety and effectiveness of metal-on-metal hip implants.”
The FDA could have avoided the hip replacement recall if only DePuy had not used the 510(k) loophole during the approval process. Only really helping companies such as DePuy, the loophole allows companies to pass the clinical trials through claims that the product is similar to a product already on the market. This was done by Depuy by convicing the government that the metal-on-metal hip replacements were new medical discovery while similar at the same to other products.
President of American Academy of Orthopaedic Surgeons, John Callaghan, commented in a release that, “We believe that a significant majority of metal-on-metal hip replacement implants have successfully relieved pain and improved function without any problems for the patients who have received them but there have been some concerning exceptions.” Hundreds if not thousands of hip replacement lawsuits have resulted due to those exceptions and the number is growing.
Thousands of hip replacement lawsuits will realistically be a direct result from these “concerning exceptions”. Those affected by the DePuy recall deserve proper compensation and should consider speaking with an experienced product liability lawyer. For more information on the FDA’s study of DePuy’s metal-on-metal implants, visit the DePuy lawsuit center.
Posted under Miscellaneous Content
This post was written by admin on April 11, 2011
